Innovative and accredited continuing medical education for today’s practicing clinicians.

CME Institute is trusted by physicians across medical specialties for premium continuing education that yields the highest educational outcomes. These ACCME-accredited activities make the latest research, novel therapies, and clinical best practices accessible and approachable for physician, NP, PA, and PharmD learners.

Expert-led insights to improve patient outcomes
Multi-modal courses to suit all learning styles
Timely topics for relevant application to practice
Razor-focused approach to innovation that includes documentary-style video and micro-learning Tweetorials
A commitment to collective mindfulness

Recent courses

Self-study / Enduring Video Acute and Maintenance Treatment Strategies for Bipolar I: Focus on Mixed and Manic Episodes Bipolar Disorder Bipolar Depression Depression Adopting consensus guidelines while applying new evidence on the latest treatment options can often be a matter of balancing risks, benefits, and tolerability when addressing acute episodes in bipolar I disorder. Sit in on the discussion between three experts as they discuss guideline-directed treatment strategies that address manic and mixed episodes in patients with bipolar I disorder, and listen to one patient’s journey to hope and recovery. 0.50 AMA PRA Category 1 Credit™ 0.50 Participation	Self-study / Enduring Video Therapeutic Tolerability and Adherence in Bipolar Disorder Bipolar Disorder Bipolar Depression Depression Involving patients in designing their own treatment strategies according to their tolerability criteria can help combat the 90% nonadherence rate in patients being treated for bipolar disorder. Find out from experts about best practices in addressing patient concerns and balancing tolerability with efficacy and adherence in treating patients with bipolar disorder. 0.50 AMA PRA Category 1 Credit™ 0.50 Participation	Self-study / Enduring Differentiating and Treating Alzheimer’s Disease Alzheimer Disease Cognition Dementia Diagnostic Tools Education Functional Impairment Geriatric Psychiatry Neuroimaging Neurology Patient/Physician Communication Drs Anderson and Malone cover the types of dementia and their indicators, ways to approach care for mild cognitive impairment (MCI) and mild dementia, and treatment options available or in the pipeline for disease intervention. Early diagnosis and intervention of MCI and mild dementia can slow disease progression and optimize outcomes for both patients and caregivers. 0.50 AMA PRA Category 1 Credit™ 0.50 Participation
Self-study / Enduring Mild Cognitive Impairment Due to Alzheimer Disease Alzheimer Disease Cognition Dementia Diagnostic Tools Education Functional Impairment Geriatric Psychiatry Neuroimaging Neurology Patient/Physician Communication Drs Anderson and Malone discuss the burden of, signs and symptoms of, diagnostic tools and criteria for mild cognitive impairment (MCI) and mild/early dementia and the benefits of early diagnosis. Early diagnosis and intervention of MCI and mild dementia can slow disease progression and optimize outcomes for both patients and caregivers. 0.50 AMA PRA Category 1 Credit™ 0.50 Participation	Self-study / Enduring Managing the Physical, Neuropsychiatric, and Cognitive Health Needs of Patients With Duchenne Muscular Dystrophy Sleep Depression Attention-Deficit/Hyperactivity Disorder Child and Adolescent Psychiatry Cognition Delivery of Care Diagnostic Tools Muscular Dystrophy Obsessive-Compulsive and Related Disorders Patient/Physician Communication Psychopharmacology Side Effects Violence/Aggression Weight This video reviews treatment guidelines for patients with DMD and emphasizes the importance of clinicians intervening early on behalf of individuals who develop behavioral-psychosocial comorbidities. 1.00 AMA PRA Category 1 Credit™ 1.00 Participation	Journal Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study Psychotic Disorders Substance Use Disorders COVID-19 Identifying risk factors that predispose individuals to negative COVID-19 outcomes is important. The current study examined the association between substance use disorders, psychiatric diagnosis, and COVID-19–related clinical outcomes. 1.00 AMA PRA Category 1 Credit™ 1.00 Participation
Self-study / Enduring Improving Standards of Care in Type 2 Diabetes with Chronic Kidney Disease: Integrating the Non-Steroidal Mineralocorticoid Antagonist Class in... Renal Disease Primary Care Patient/Physician Communication Side Effects Cardiology Metabolic Disorders Diagnostic Tools How to screen UACR and eGFR levels, implement selective non-steroidal MRA therapies, and mitigate the risk of hyperkalemia to prevent CKD disease progression 1.00 AMA PRA Category 1 Credit™ 1.00 Participation	Journal Treatment-Resistant Mood Disorders in LGBTQ People: A Retrospective Study of Clinical Features and Response to Electroconvulsive Therapy Mood Disorders Depression Electroconvulsive Therapy In this chart review, LGBTQ people with treatment-resistant mood disorders had clinical features linked to worse outcomes, but their improvement with ECT was similar to that seen in non-LGBTQ patients. 1.00 AMA PRA Category 1 Credit™ 1.00 Participation	Journal The Co-occurrence of Gastrointestinal Symptoms and Psychosis: Diagnostic Considerations Psychotic Disorders Gastroenterology There are numerous clinical scenarios in which gastrointestinal and psychotic symptoms commonly co-occur; thus, it is important that both psychiatrists and primary care physicians have a familiarity with the differential diagnosis. 1.00 AMA PRA Category 1 Credit™ 1.00 Participation
Journal Suicide Risk in a National VA Sample: Roles of Psychiatric Diagnosis, Behavior Regulation, Substance Use, and Smoking Bipolar Disorder Schizophrenia/ Schizoaffective Disorders Smoking Substance Use Disorders Suicide Veterans and Military Issues Predicting suicide is difficult, as suicidal behavior is not linked solely to any single behavior or psychiatric diagnosis. This study compared risk of suicidal behavior among a transdiagnostic sample of Veterans with varying disorders and behaviors. 1.00 AMA PRA Category 1 Credit™ 1.00 Participation	Tweetorial Self-study / Enduring Tweetorial: Diagnosing and Treating Alzheimer Disease During the Early Stage Alzheimer Disease Dementia Integrated Care Neuroimaging Patient/Physician Communication Primary Care Prompt treatment of early-stage Alzheimer disease (AD) can curb symptom progression. Tests for biomarkers, new symptomatic treatments and disease-modifying agents, and the addition of the preclinical stage to AD diagnostic criteria can aid in earlier disease recognition and building treatment plans. 0.25 AMA PRA Category 1 Credit™ 0.25 Participation	Video Facilitating Treatment Initiation in Early-Stage Alzheimer Disease Alzheimer Disease Dementia Integrated Care Neuroimaging Patient/Physician Communication Primary Care Many new therapies for early-stage AD have made their way onto the scene that can delay onset of the disease and/or slow down progression. Find out the how, what, when to better treat your patients with AD from specialists in the field. 0.50 AMA PRA Category 1 Credit™ 0.50 Participation

Pages

My Courses

Please login or create an account to view your activities.

Transcript

Please login or create an account to view your activities.